Lucy’s Weight Loss System of Arlington, Texas, has expanded its recall of diet pills to include all lots of Pink Bikini and Shorts on the Beach capsules in all colors, 30 count, after an analysis found the products to contain potentially dangerous undeclared drug ingredients.
Pink Bikini (white capsules, blue capsules and gold capsules) and Shorts of the Beach (blue capsules and gold capsules) were found to contain sibutramine, phenolphthalein and/or diclofenac, which were not listed on the products’ labels.
Sibutramine is an appetite suppressant that was sold under the brand name Meridia and pulled from the U.S. market in October 2010 due to serious health risks. The drug can substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke.
Phenophtalein is not approved in the U.S. Health risks associated with this drug include serious gastrointestinal disturbances, irregular heartbeat, and cancer with long-term use.
Diclofenac is a non-steroidal anti-inflammatory drug (NSAID). Patients already taking an NSAID, people with allergies, those with an underlying illness, or people who have recently undergone cardiac bypass surgery who use diclofenac are at an increased risk of gastrointestinal disturbances, fatal heart attack, or stroke.
Pink Bikini and Shorts on the Beach were distributed nationwide to consumers through PinkBikini.BigCartel.com and through Waisted With Lucy retail stores. Anyone with these products are advised to stop using them and to contact their doctors if they experience any side effects after using these products.
Any side effects or adverse events related to these products should be reported to the FDA MedWatch Adverse Event Reporting Program at www.FDA.gov/MedWatch/Report.htm.